Press Releases 2019

September

THURSDAY, SEPTEMBER 5, 2019

CDC Telebriefing: Update on Pulmonary Disease Associated with E-cigarettes

August

FRIDAY, AUGUST 23, 2019

CDC Telebriefing: CDC Update on Severe Pulmonary Disease Associated with E-cigarettes

TUESDAY, AUGUST 6, 2019

CDC Telebriefing: New Vital Signs Report – Wide Variation in Naloxone Prescribing

September

FRIDAY, SEPTEMBER 6, 2019

Transcript of September 6, 2019, Telebriefing: Investigation of Pulmonary Disease Among People Who Use E-cigarettes

Audio Recording media icon[MP3, 9.0 MB]

August

FRIDAY, AUGUST 23, 2019

Transcript of August 23, 2019, Telebriefing on Severe Pulmonary Disease Associated with Use of E-cigarettes

Audio Recording media icon[MP3, 5 MB]

TUESDAY, AUGUST 6, 2019

Transcript for CDC Vital Signs Teleconference: Naloxone

Audio Recording media icon[MP3, 4.03 MB]

September

THURSDAY, SEPTEMBER 12, 2019

CDC, states update number of cases of lung disease associated with e-cigarette use, or vaping

WEDNESDAY, SEPTEMBER 11, 2019

Statement from CDC Director Robert R. Redfield, M.D., on FDA plan to remove non-tobacco-flavored e-cigarettes from market

August

FRIDAY, AUGUST 30, 2019

Statement from CDC Director Robert R. Redfield, M.D., and Acting FDA Commissioner Ned Sharpless, M.D., on federal and state collaboration to investigate respiratory illnesses reported after use of e-cigarette products

WEDNESDAY, AUGUST 21, 2019

CDC, FDA, States Continue to Investigate Severe Pulmonary Disease Among People Who Use E-cigarettes

SATURDAY, AUGUST 17, 2019

CDC, states investigating severe pulmonary disease among people who use e-cigarettes

April

WEDNESDAY, APRIL 24, 2019

CDC Advises Against Misapplication of the Guideline for Prescribing Opioids for Chronic Pain